Other
Dentin Hypersensitivity
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Dentin Hypersensitivity is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
28
clinical trials
Completed19 · 68%
Unknown status5 · 18%
Recruiting2 · 7%
Withdrawn1 · 4%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
28 trials
Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT02918617·203 enrolled
Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment
Completed·—·N/A·NCT02931734·140 enrolled
Effect of Gluma and Bioactive Glass Desensitizers in Treatment of Dentin Hypersensitivity in Cervical Non-Carious Lesions
Completed·—·N/A·NCT07063433·40 enrolled
Comparative Study on the Efficacy of OliNano SEAL and Curodont D' Senz in Treatment of Dentin Hypersensitivity
Completed·—·Phase 4·NCT05122312·70 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)